0001351615-16-000003.txt : 20160330 0001351615-16-000003.hdr.sgml : 20160330 20160330103437 ACCESSION NUMBER: 0001351615-16-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160330 DATE AS OF CHANGE: 20160330 EFFECTIVENESS DATE: 20160330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SIAMAB THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001351615 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-237587 FILM NUMBER: 161537418 BUSINESS ADDRESS: STREET 1: 48 WILDE ROAD CITY: NEWTON STATE: MA ZIP: 02468 BUSINESS PHONE: 800-513-1569 MAIL ADDRESS: STREET 1: 48 WILDE ROAD CITY: NEWTON STATE: MA ZIP: 02468 FORMER COMPANY: FORMER CONFORMED NAME: Sialix, Inc. DATE OF NAME CHANGE: 20110817 FORMER COMPANY: FORMER CONFORMED NAME: Gc-Free, Inc. DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: GcFree Inc DATE OF NAME CHANGE: 20060131 D/A 1 primary_doc.xml X0707 D/A LIVE 0001351615 SIAMAB THERAPEUTICS, INC. 90 Bridge Street, Suite 100 NEWTON MA MASSACHUSETTS 02458 800-513-1569 DELAWARE Sialix, Inc. Gc-Free, Inc. GcFree Inc Corporation true Jeffrey Behrens c/o Siamab Therapeutics, Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Executive Officer Director Brad Curley c/o Siamab Therapeutics, Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Director Robert Mashal c/o Siamab Therapeutics, Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Director Gary Pforzheimer c/o Siamab Therapeutics, Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Director Peter Kroon c/o Siamab Therapeutics,Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Director Biotechnology Decline to Disclose 06b true 0001351615-15-000001 2015-03-30 true true true false 0 7000000 3213332 3786668 false 64 0 0 0 false SIAMAB THERAPEUTICS, INC. /s/ Jeffrey Behrens Jeffrey Behrens President and Chief Executive Officer 2016-03-29